Thursday 07 July 2022
Internal Reference Number: FOI_4779
Date Request Received: 24/12/2018 08:43:22
Date Request Replied To: 03/01/2019 09:45:42
This response was sent via: By Email
Request Summary: Compounded bevacizumab - wet age-related macular degeneration
Request Category: Companies
| Question Number 1: Does your Trust have, or intend to introduce, a policy that makes compounded bevacizumab routinely available to treat wet age-related macular degeneration? If yes please supply a copy of your policy. | |
| Answer To Question 1: No plans to introduce at the current time. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
